Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

LON/NFX stock hub

LON/NFX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/NFXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.3M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/NFX

In the news

Latest news · LON/NFX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-88.8

P25 -54.2P50 2.1P75 13.7

ROIC-100.5

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/NFX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

139

Groups with data

Currency

GBP

Showing 139 of 139 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	3
Employees Change	-1%
Employees Change Percent	-25
Enterprise value	GBX 5.3M
Exchange	London Stock Exchange
Financial currency	GBP
First seen	2026-05-10
Industry	Biotechnology
Isin	GB00BYW79Y38
Last refreshed	2026-05-10
Market cap	GBX 5.3M
Price	GBX 0.19
Price currency	GBX
Sector	Healthcare
Sic	2834
Symbol	lon/NFX
Website	https://www.nuformix.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-12.2%
EV Earnings	-8.05x
P/B ratio	7.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	GBX -652,586
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Profit Per Employee	GBX -217,529
ROA	-41.51
ROCE	-87.5
ROE	-88.76
ROIC	-100.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	54.9%
Cagr3y	-8.79%
Cagr5y	-38.95%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	GBX 1M
Cash	GBX 97,550
Current Assets	GBX 136,074
Current Liabilities	GBX 263,922
Equity	GBX 754,934
Liabilities	GBX 263,922
Long Term Assets	GBX 882,782
Long Term Liabilities	GBX 0
Net Cash	GBX 97,550
Net Cash By Market Cap	GBX 1.82
Net Cash Growth	382.68%
Net Debt Equity	GBX -0.13
Tangible Book Value	GBX -127,850
Tangible Book Value Per Share	GBX -0
WACC	12.5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.52
Net Working Capital	GBX -225,398
Quick ratio	0.43
Working Capital	GBX -127,848

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-107.27%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	54.85%
200-day SMA	0.21
3Y total return	-24.12%
50-day SMA	0.2
50-day SMA vs 200-day SMA	50under200
5Y total return	-91.51%
All Time High	14.89
All Time High Change	-98.72%
All Time High Date	2019-06-24
All Time Low	0.04
All Time Low Change	375%
All Time Low Date	2024-11-04
ATR	0.03
Beta	1.5
Beta1y	0.24
Beta2y	0.06
Ch YTD	-25.49
High	0.22
High52	0.56
High52 Date	2025-11-04
High52ch	-65.77%
Low	0.17
Low52	0.07
Low52 Date	2025-05-22
Low52ch	171.43%
Ma50ch	-3.6%
Price vs 200-day SMA	-11.42%
RSI	59.15
RSI Monthly	47
RSI Weekly	48.72
Sharpe ratio	0.99x
Sortino ratio	1.87
Total Return	-107.27%
Tr YTD	-25.49
Tr1m	8.57%
Tr1w	11.77%
Tr3m	-17.39%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -660,569

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,505,280,027%
Shares Insiders	3.81%
Shares Institutions	66.48%
Shares Out	2,609,749,903
Shares Qo Q	37.36%
Shares Yo Y	107.27%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	23,550,404.2x
Bv Per Share	0
Ch1m	8.57
Ch1w	11.77
Ch1y	52
Ch3m	-17.39
Ch3y	-25.49
Ch5y	-91.67
Ch6m	-47.95
Change	0%
Change From Open	4.51
Close	0.19
Days Gap	-4.32
Depreciation Amortization	28,627
Dollar Volume	9,230,518.3
Earnings Date	2026-05-15
EBIT	GBX -660,569
EBITDA	GBX -631,942
EPS	GBX -0
F Score	1
Financing CF	691,950
Fiscal Year End	September
Founded	2,008
Goodwill	882,784
Income Tax	GBX -7,983
Is Primary Listing	1
Last Earnings Date	2026-01-30
Last Report Date	2025-09-30
Ma150	0.25
Ma150ch	-24.09%
Ma20	0.18
Ma20ch	6.2%
Net CF	77,340
Next Earnings Date	2026-05-15
Open	0.18
Position In Range	41.67
Price Date	2026-05-08
Relative Volume	2.14x
Tr6m	-47.95%
Volume	48,581,675

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/NFX pay a dividend?

Capital-return profile for this ticker.

Performance

LON/NFX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/NFX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+66.5%

Share of float held by funds and institutions

Insider ownership

+3.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+107.3%

Negative means the company is buying back shares.

Technical

LON/NFX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

59.1

Neutral momentum band

Price vs 200-day MA

-11.4%

50/200-day relationship not available

Beta (5Y)

1.50

More volatile than the market

Sharpe ratio

0.99

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/NFX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/NFX stock rating?

lon/NFX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/NFX analysis?

The full report lives at /stocks/lon/NFX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/NFX?

The latest report frames lon/NFX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/NFX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.